home / stock / blph / blph news

BLPH News and Press, Bellerophon Therapeutics Inc. From 08/11/20

Stock Information
Company Name: Bellerophon Therapeutics Inc.
Stock Symbol: BLPH
Market: OTC
Website: bellerophon.com
Menu
BLPH BLPH Quote BLPH Short BLPH News BLPH Articles BLPH Message Board
Get BLPH Alerts

News, Short Squeeze, Breakout and More Instantly...
BLPH - Bellerophon Appoints Cardiopulmonary Disease Expert Wassim Fares, M.D., MSCR, as Chief Medical Officer

WARREN, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, announced today ...
BLPH - Bellerophon Therapeutics EPS beats by $0.21

Bellerophon Therapeutics (NASDAQ: BLPH ) : Q2 GAAP EPS of -$0.51 beats by $0.21 . Cash and cash equivalents of $59.3M. Press Release More news on: Bellerophon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,

BLPH - Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results

WARREN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today provided a...

BLPH - Galera Phase 2 Trial, And Other News: The Good, Bad And Ugly Of Biopharma

Galera Therapeutics Advances Mid Stage Clinical Trial of GC4419 Galera Therapeutics Inc. ( GRTX ) reported that it has completed the process of patient enrollment for its Phase 1b/2a clinical trial of avasopasem manganese or GC4419. The drug candidate is being assessed for safety and ant...
BLPH - Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results

Patients Treated with INOpulse® Demonstrated Improved Physical Activity Compared to Placebo Live Webinar with Study Investigators on Thursday, July 16 th , from 4:00-5:00 pm EDT WARREN, N.J., July 15, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a cli...

BLPH - Bellerophon advances late-stage study of INOpulse for COVID-19

Bellerophon Therapeutics ( BLPH +4.8% )  announces that the first patient has initiated treatment in Phase 3 study of INOpulse inhaled nitric oxide therapy for COVID-19. More news on: Bellerophon Therapeutics, Inc., Healthcare stocks news, Read more ...

BLPH - Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19

WARREN, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that the first patient has initiated treatment in the Company...
BLPH - ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes

Orgenesis (NASDAQ: ORGS ) added to the Russell 3000 Index, effective after the market open June 29 . More news on: Orgenesis Inc., Soleno Therapeutics, Inc., Cidara Therapeutics, Inc., Healthcare stocks news, Read more ...

BLPH - Bellerophon Therapeutics Added to Russell 3000® and Microcap® Indexes

WARREN, N.J., June 29, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases, today announced that the company has been added to the Russell 3000 ...

BLPH - Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares

WARREN, N.J., May 22, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”) today announced the closing of its previously announced public offering and concurrent registered direct offering (the “Offerings&...
Previous 10 Next 10